Massimo Baraldo

1.4k total citations
60 papers, 1.0k citations indexed

About

Massimo Baraldo is a scholar working on Pharmacology, Transplantation and Epidemiology. According to data from OpenAlex, Massimo Baraldo has authored 60 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pharmacology, 15 papers in Transplantation and 12 papers in Epidemiology. Recurrent topics in Massimo Baraldo's work include Antibiotics Pharmacokinetics and Efficacy (23 papers), Renal Transplantation Outcomes and Treatments (15 papers) and Antimicrobial Resistance in Staphylococcus (8 papers). Massimo Baraldo is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (23 papers), Renal Transplantation Outcomes and Treatments (15 papers) and Antimicrobial Resistance in Staphylococcus (8 papers). Massimo Baraldo collaborates with scholars based in Italy, United States and United Kingdom. Massimo Baraldo's co-authors include Mario Furlanut, Federico Pea, Pier Giorgio Cojutti, Guang Wu, Loretta Franceschi, Ugolino Livi, Michele Baccarani, Cristiano Chiamulera, Miriam Isola and Mariagrazia Michieli and has published in prestigious journals such as Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Massimo Baraldo

59 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Massimo Baraldo Italy 19 324 206 158 153 125 60 1.0k
Manuel Pestana Portugal 26 54 0.2× 113 0.5× 202 1.3× 79 0.5× 70 0.6× 145 2.1k
Olivier Tribut France 19 296 0.9× 298 1.4× 416 2.6× 19 0.1× 130 1.0× 48 1.4k
Jane C. Gillis 12 168 0.5× 69 0.3× 174 1.1× 113 0.7× 91 0.7× 15 1.3k
Barbara J. Philips United Kingdom 22 78 0.2× 208 1.0× 308 1.9× 18 0.1× 68 0.5× 54 1.9k
Tina Mele Canada 17 33 0.1× 102 0.5× 262 1.7× 147 1.0× 85 0.7× 53 1.6k
James N. Fullerton United Kingdom 15 88 0.3× 90 0.4× 461 2.9× 31 0.2× 157 1.3× 22 2.2k
Stefano Federico Italy 22 46 0.1× 82 0.4× 280 1.8× 394 2.6× 106 0.8× 66 1.4k
Guang‐Shing Cheng United States 21 183 0.6× 178 0.9× 286 1.8× 45 0.3× 234 1.9× 63 1.3k
Bruna Guida Italy 26 70 0.2× 38 0.2× 108 0.7× 51 0.3× 26 0.2× 75 1.6k
Guillermo Di Girolamo Argentina 22 116 0.4× 74 0.4× 84 0.5× 21 0.1× 77 0.6× 107 1.3k

Countries citing papers authored by Massimo Baraldo

Since Specialization
Citations

This map shows the geographic impact of Massimo Baraldo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Baraldo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Baraldo more than expected).

Fields of papers citing papers by Massimo Baraldo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Massimo Baraldo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Baraldo. The network helps show where Massimo Baraldo may publish in the future.

Co-authorship network of co-authors of Massimo Baraldo

This figure shows the co-authorship network connecting the top 25 collaborators of Massimo Baraldo. A scholar is included among the top collaborators of Massimo Baraldo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Massimo Baraldo. Massimo Baraldo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Angelini, Jacopo, et al.. (2025). PK/PD Analysis of High-Dose Daptomycin Use in the Treatment of Bone and Joint Infections: Data from a Real-World Setting. Microorganisms. 13(2). 304–304. 3 indexed citations
2.
Giuliano, Simone, et al.. (2024). Renal function and its impact on the concentration of ceftazidime-avibactam: A cross-sectional study. International Journal of Antimicrobial Agents. 64(6). 107351–107351. 3 indexed citations
3.
Angelini, Jacopo, Shuhan Liu, Luca Martini, et al.. (2024). Revolutionizing Daptomycin Dosing: A Single 7–11-Hour Sample for Pragmatic Application. Clinical Infectious Diseases. 79(3). 596–599. 4 indexed citations
4.
Giuliano, Simone, Jacopo Angelini, Assunta Sartor, et al.. (2023). Ampicillin and Ceftobiprole Combination for the Treatment of Enterococcus faecalis Invasive Infections: “The Times They Are A-Changin”. Antibiotics. 12(5). 879–879. 10 indexed citations
5.
6.
Baldan, Federica, Patrizia Tulissi, M Gropuzzo, et al.. (2019). Tacrolimus Therapeutic Drug Monitoring in Stable Kidney Transplantation and Individuation of CYP3A5 Genotype. Transplantation Proceedings. 51(9). 2917–2920. 6 indexed citations
7.
Baraldo, Massimo. (2016). Meltdose Tacrolimus Pharmacokinetics. Transplantation Proceedings. 48(2). 420–423. 19 indexed citations
8.
Cojutti, Pier Giorgio, Miriam Isola, Massimo Baraldo, et al.. (2016). Might isoniazid plasma exposure be a valuable predictor of drug-related hepatotoxicity risk among adult patients with TB?. Journal of Antimicrobial Chemotherapy. 71(5). 1323–1329. 15 indexed citations
9.
Franceschi, Loretta, Pier Giorgio Cojutti, Massimo Baraldo, & Federico Pea. (2014). Stability of Generic Meropenem Solutions for Administration by Continuous Infusion at Normal and Elevated Temperatures. Therapeutic Drug Monitoring. 36(5). 674–676. 33 indexed citations
10.
Grassi, M, Cristiano Chiamulera, Massimo Baraldo, et al.. (2012). Cigarette Smoking Knowledge and Perceptions Among Students in Four Italian Medical Schools. Nicotine & Tobacco Research. 14(9). 1065–1072. 28 indexed citations
11.
Baraldo, Massimo. (2008). The influence of circadian rhythms on the kinetics of drugs in humans. Expert Opinion on Drug Metabolism & Toxicology. 4(2). 175–192. 138 indexed citations
12.
Baraldo, Massimo & Mario Furlanut. (2006). Chronopharmacokinetics of Ciclosporin and Tacrolimus. Clinical Pharmacokinetics. 45(8). 775–788. 39 indexed citations
13.
Baraldo, Massimo, Miriam Isola, Anna Francesconi, et al.. (2005). Therapeutic Mycophenolic Acid Monitoring by Means of Limited Sampling Strategy in Orthotopic Heart Transplant Patients. Transplantation Proceedings. 37(5). 2240–2243. 28 indexed citations
14.
Baraldo, Massimo, et al.. (2002). Therapeutic Drug Monitoring of Lamotrigine in Patients Suffering from Resistant Partial Seizures. European Neurology. 48(4). 200–203. 12 indexed citations
15.
Baraldo, Massimo, et al.. (2001). Pharmacokinetics of two oral cyclosporin a formulations in clinically stable heart-transplant patients. Pharmacological Research. 43(6). 547–551. 4 indexed citations
16.
17.
Baraldo, Massimo, Gianfranco Ferraccioli, Federico Pea, Elisa Gremese, & Mario Furlanut. (1999). CYCLOSPORINE A PHARMACOKINETICS IN RHEUMATOID ARTHRITIS PATIENTS AFTER 6 MONTHS OF METHOTREXATE THERAPY. Pharmacological Research. 40(6). 483–486. 4 indexed citations
18.
Damiani, Daniela, Mariagrazia Michieli, Anna Ermacora, et al.. (1998). Adjuvant treatment with cyclosporin A increases the toxicity of chemotherapy for remission induction in acute non-lymphocytic leukemia. Leukemia. 12(8). 1236–1240. 18 indexed citations
19.
Furlanut, Mario, et al.. (1997). LEVODOPA AND 3-O-METHYLDOPA IN CEREBROSPINAL FLUID AFTER LEVODOPA-CARBIDOPA ASSOCIATION. Pharmacological Research. 35(4). 313–315. 27 indexed citations
20.
Furlanut, Mario, et al.. (1996). Blood Concentrations and Clinical Effect of Cyclosporin in Psoriasis. Therapeutic Drug Monitoring. 18(5). 544–548. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Manuel Pestana Breakdown of academic impact, for papers by Olivier Tribut Breakdown of academic impact, for papers by Jane C. Gillis Breakdown of academic impact, for papers by Barbara J. Philips Breakdown of academic impact, for papers by Tina Mele Breakdown of academic impact, for papers by James N. Fullerton Breakdown of academic impact, for papers by Stefano Federico Breakdown of academic impact, for papers by Guang‐Shing Cheng Breakdown of academic impact, for papers by Bruna Guida Breakdown of academic impact, for papers by Guillermo Di Girolamo
Rankless by CCL
2026